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Methods 
Survey development and design 
The questionnaire was written with input from all authors.  The final survey consisted of 11 
questions: 5 multiple choice questions gathering demographic and occupational data 
regarding respondents, 5 free text options gathering opinions regarding research priorities 
and how research may need to adjust to a world with COVID.  The final question was a free 
text option for any additional comments. The survey questions are given below.  
 
Survey administration 
The questions were uploaded to SurveyMonkey (www.surveymonkey.com) and a weblink to 
the survey site was distributed along with an invitation to participate in the survey. The 
survey was advertised via professional networks connected to the authors, including the 
British Geriatrics Society, European Union Geriatric Medicine Society, Chartered Society of 
Physiotherapists in the UK, NIHR Clinical Research Networks for Ageing, Dementia and 
Neurodegeneration, and was widely shared on Twitter through the above organisations and 
through internationally connected influencers in geriatric medicine. Survey responses were 
fully anonymised and no identifiable information was collected.  No ethical approval was 
required or sought for the survey. The survey was open to responses from anywhere in the 
world from 8th May 2020 to 16th May 2020. 
 
Data analysis 
Responses were downloaded from SurveyMonkey as Microsoft Excel files and were analysed 
in SPSS v24 (IBM, New York, USA).  Open responses were divided into themes that emerged 
from the data, with no prespecified framework imposed. Responses were kept deliberately 
broad to minimise the number of thematic categories. Categorisation was performed by SR 
and checked by MDW. Descriptive statistics on the respondents and the frequency of 
themes were generated; where a respondent had given duplicate or very similar responses 
within a question, the response was counted only once.  
 
Results 
267 respondents completed the survey. Details on country, profession and specialty interest 
are shown in Table 1.  Figures 1-4 show the frequency with which responses were given to 
the questions regarding research priorities, design and delivery.  Tables 2-6 give subthemes 




1. What country are you based in? England / Wales / Scotland / Northern Ireland / 
Other (free text) 
2. Are you a: non-clinical academic / clinical academic / clinician 
3. If you are a researcher, are you an: early career researcher (pre-doctoral or <5 yrs 
postdoctoral) / experienced researcher (>5 yrs postdoctoral) / not a researcher 
4. Is your area of expertise: Dementia / Stroke / Movement disorders / Other geriatric 
medicine / Other (free text) 
5. What is your profession: Doctor / Nurse / Physiotherapist / Occupational therapist / 
Other (free text) 
6. How has the COVID-19 pandemic changed how research for older people is 
conducted in your organisation? (free text) 
7. Regarding research on COVID-19 and older people, what three areas/topics should 
be prioritised? (free text) 
8. How do you think the design of research studies for older people (not just for 
COVID) will need to change in a world with COVID (top 3 suggestions, free text) 
9. How does the way we conduct research studies in practice (not just for COVID) need 
to change in a world with COVID (top 3 suggestions, free text) 
10. What are the top three lessons you have learned as a result of the impact that 
COVID-19 has had on research for older people (free text) 




Table 1. Details of survey respondents 
  N (%) 
Country England 162 (60.7) 
Wales 2 (0.7) 
Scotland 51 (19.1) 
Northern Ireland 6 (2.2) 
Other European 31 (11.6) 
Rest of world 15 (5.6) 
 
Clinician / academic Clinician, non-academic 89 (33.3) 
Academic, non-clinician 57 (21.3) 
Clinical academic 119 (44.6) 
Other 2 (0.7) 
 
Research career stage Early career researcher 67 (25.1) 
Experienced researcher 124 (46.4) 
Not a researcher 76 (28.5) 
 
Area of expertise Dementia 73 (27.3) 
Stroke 24 (9.0) 
Movement disorders 30 (11.2) 
Other geriatric medicine 98 (36.7) 
Other 42 (15.7) 
 
Professional group Doctor 163 (61.0) 
Nurse 21 (7.9) 
Physiotherapist 17 (6.4) 
Occupational therapist 3 (1.1) 
Speech and language therapist 1 (0.4) 
Pharmacist 3 (1.1) 
Dietician 4 (1.5) 
Psychologist 10 (3.7) 
Academic 26 (9.7) 





Figure 1. Most common ways that COVID-19 has impacted on research for older people: 
 
  
Figure 2. Most popular topics to prioritise for COVID-19 research: 
 
Figure 3. Most popular ways that research design needs to change in a world with COVID-19: 
 
 
Figure 4. Most popular ways that research delivery needs to change in a world with COVID-19: 
 
Themes and subthemes 
Table 2. How has the COVID-19 pandemic changed how research for older people is conducted in your 
organisation? 
 
1. Recruitment to non-COVID studies suspended 
 
2. No face to face contact – e.g. move to remote follow-up, challenges of this new way of working, 
focus on existing data-sets and using routinely collected data 
 
3. Focus on COVID research 
 
4. Positive changes seen – e.g. collaboration, opportunities to contribute to large research studies, 
accelerated writing and approvals with more streamlined processes, more interest in research, 
research more inclusive of older people, more interest in care homes 
 
5. Redeployment of research staff – e.g. clinical academics moved back to clinical work, research 
nurses pulled back to clinical duties, non-COVID researchers moved to COVID studies 
 
6. Workforce challenges – e.g. challenges of working from home - “virtual existence”, remote 
supervision and meetings, conferences and training courses cancelled, freezing of recruitment, 
threat to career progression 
 
7. Laboratory based research stopped 
 
8. No change 
 
9. Grants/fellowships suspended – e.g. grants and fellowships suspended or cancelled, concerns 
regarding whether funders will extend studies to allow for the current pause due to COVID 
 






Table 3. Regarding research on COVID-19 and older people, what three areas/topics should be prioritised? 
 
1. Management of COVID and its complications – e.g. complications including delirium, coagulopathy, 
optimal management in intensive care unit (ICU) and non-ICU settings, palliative care, drug trials, 
patient experience, ethical decision making, rehabilitation post-COVID, supporting staff 
 
2. Epidemiology – e.g. detailed documentation of presentation, particularly in subgroups including 
those with dementia, improve recognition and develop screening tools, prognosis including who 
might benefit from ITU, post-COVID complications and longer term implications including 
dementia, impact of COVID on frailty/function/quality of life/sarcopenia, additional care needs post 
infection, accurate data collection methods 
 
3. Wider societal impact of COVID – e.g. impacts of lockdown on cognition, mental health, mobility, 
nutrition, mitigating impacts of isolation, supporting carers, elder abuse, optimising health and 
wellbeing during isolation, challenges specific to certain conditions e.g. dementia 
 
4. Consequences of the pandemic for other healthcare delivery – e.g. experiences of hospital, novel 
approaches to providing usual care, access to secondary care, or lack of it, impact of lack of 
attendance at primary and secondary care, transitions of care – better understanding of and how 
to improve, challenges of using personal protective equipment, structure of community services 
 
5. Care home research – e.g. epidemiology, impact on care home staff and residents, sharing 
knowledge and lessons learned, outbreak management, investment more generally in care home 
research, perceptions of care homes amongst the general public 
 
6. Public health interventions – e.g. prevention strategies including vaccine, testing including antibody 
tests and availability of this, develop a model for optimal care for future pandemics, interventions 
to promote healthy behaviours, involvement of older people in development of recommendations 
 
7. Communication in pandemic situations – e.g. with relatives and carers, use of technology - evaluate 
remote interventions, telemedicine, self management, patient and carer understanding and 
acceptability of treatment escalation plans and advance care planning, bereavement, impact on 
death certification and reporting 
 
8. Pathophysiology of COVID infection in older people – e.g. why are older people more at risk, 
understand the immune response to COVID and development of immunity, transmission 
 
9. Research methodology – e.g. patient related outcome measures, inclusion of older people in 
research, maximum outputs from minimal contact, remote assessments, how to continue research 





Table 4. How do you think the design of research studies for older people (not just for COVID) will need to 
change in a world with COVID? 
 
1. Remote working – e.g. avoid face-to-face contact with participants, reduce need for older people 
to attend hospitals for follow up, post study drugs, separate hospital sites from research sites, new 
methods of patient and public involvement, increased use of remote follow up, questionnaires, 
self reported outcomes 
 
2. Inclusivity – e.g. no upper age limits, include those who are shielding, lack capacity, live in care 
homes, all ethnicities, at all stages of studies, from priority setting to design to dissemination, a 
focus on personal choice around exposure to risk, provide teaching as part of study on how to use 
the technology, advocating for outcome measures relevant to our cohort, lay summaries for all 
published studies 
 
3. Embracing technology and innovation – e.g. to facilitate non face-to-face contact with participants, 
novel data collection tools, passive devices to monitor participants remotely, particularly for 
qualitative research, ensuring these do not exclude older population, awareness of limitations of 
technologies and potential recruitment bias  
 
4. Infection control – e.g. increased awareness and appreciation of infection control, develop 
standard operating procedures for environmental cleaning and personal protective equipment in 
research studies, risk assessments, increased staffing to allow for COVID versus non-COVID 
workforce, access to testing, flexibility in terms of timing of visits to avoid travelling at peak times 
 
5. Use of routinely collected data and linkage – e.g. including drive for more observational studies, 
facilitating delivery of such studies in terms of approvals and access 
 
6. Efficiency drive – e.g. maximising outputs, reduce number of study visits and length of follow up, 
large, simpler and pragmatic study designs, pandemic contingency built in to all studies, core 
outcome sets, improve integration of research into routine care to avoid additional visits to 
hospital 
 
7. Pragmatic recruitment – e.g. novel consent process including online  
 
8. Collaboration – e.g. inclusivity of sites, across disciplines and specialties as well as worldwide, 
between community and hospitals, social and health care, public health etc, between researchers 
and stakeholders 
 
9. Streamlining processes – e.g. from idea conception to study approvals to study set up to 
recruitment to dissemination and transfer into practice, ensure scrutiny of protocols maintained 
 
10. Research on hold, stopped or no change 
 




Table 5. How does the way we conduct research studies in practice (not just for COVID) need to change in 
a world with COVID 
 
1.  Reduce face to face meetings – e.g. remote consultations, use of online/teleconference 
tools, with research participants as well as amongst study team, virtual conferences, 
combine research visits with clinical care, streamlining studies, remote outcome measures, 
empowerment of participants to collect own data, novel data collection strategies 
 
2. Collaboration – e.g. collaborations with clinicians so that research occurs simultaneously 
with clinical care, between all care providers, fewer studies, more efficiency, minimum data 
sets for studies, working with older people to set priorities and relevant outcomes 
 
3. Risk management – e.g. use of personal protective equipment routine, may involve testing 
of researchers, more risk assessments 
 
4. Big data – e.g. use of routinely collected data, easier access, disease registries, sharing data 
 
5. Streamlined approvals - no less stringent 
 
6. More community based research – e.g. home visits/ including community recruitment, 
study households rather than just individuals 
 
7. Flexible protocols – e.g. contingency for potential further waves – will require more 
preparation, pragmatism 
 
8. Change consent procedures – e.g. more remote consent 
 
9. Formal time set aside for research in job plan – e.g. important as research staff being pulled 
back to clinical duties, seconding staff to research 
 
10. More staff 
 





Table 6. What are the top three lessons you have learned as a result of the impact that COVID-19 has had 
on research for older people 
 
1.  Flexibility and resilience – e.g. crisis is opportunity, adapt research ideas and studies to 
current conditions, be aware of global trends, need to build in flexibility to future studies 
and alternative plans if further pandemic, streamlining of research – less research but 
better focused and prepared, alternative consent processes, particularly in those who lack 
capacity, managing uncertainty  
 
2. Societal views on ageing and the older population – e.g. ageism remains rife, no 
geriatricians on any of the influential national organisations advising research or clinical 
strategy, older people are often excluded but must include them, researchers in this field 
finding their voices, lack of prioritising care homes, some clinicians do not view ageing 
research as important, views differ around the world 
 
3. Collaboration – e.g. galvanised the group, multi-disciplinary team essential, big data really 
helpful, missed opportunities to learn from existing data due to longstanding issues about 
access/collation, important to include people with skills regarding research in older people 
in designing studies, grant applications and studies 
 
4. We can work virtually/remotely – e.g. importance of technology – upskilling with 
technology has been achieved, don’t actually always need face to face meetings, 
participants can adapt quickly to virtual interventions, remote consultations can be 
effective and patients are agreeable  
 
5. Opportunity to reflect – e.g. why research is important, opportunity to reappraise 
traditional ways of working, emphasised the gaps in our knowledge regarding biological 
mechanisms of geriatric syndromes, emphasised lack of care home research, older people 
are extremely important participants in research, studies during the pandemic have shown 
that both hospital and community settings can be successful 
 
6. Research very challenging during a pandemic – e.g. all research has stopped, essential 
research cannot currently take place, applied health research particularly challenging 
 
7. Speed – e.g. things can happen quickly when they need to but not at the expense of quality 
or rigorous ethical review, need for rapid assessment of emerging literature 
 
8. We work with a vulnerable group – e.g. vulnerable to pandemic, difficult to reach when 
isolating, may result in greater risk of older people being excluded from studies 
 
9. Patients still keen to take part – e.g. more interest in research, research with older people 
is still possible, older people should be included in all research studies 
 
10. Isolation – e.g. learnt what it feels like, research is very difficult when isolating, older 
people deteriorate quickly without social interaction, face to face contact invaluable, miss 
interacting with older people 
 
11. Clinical work prioritised – e.g. clinical academic posts are vulnerable, research isn’t 
perceived to be important 
 
12. Resources scarce – e.g. charitable funding vulnerable, research careers vulnerable, 
emphasised lack of resource in older people’s medicine to support research, emphasised 
the chronic lack of funding as no resilience in times of crisis 
 
13. None/too early to say 
 
14. Learning points regarding novel methods and tools – e.g. easy to incorporate tools relevant 
to older people into research but may be completed inaccurately, caution when applying 
tools designed for older people to younger cohorts e.g. clinical frailty scale 
 
15. People are scared and need reassurance  
 
16. Prioritise safety – e.g. protect researchers and participants 
 
17. More specialists are interested in acute disease in older people  
 
18. Infectious diseases can still lead to pandemics 
 
19. Misuse of evidence in policy and politics 
 
 
 
